REGISTRATION IS OPEN!

SHERATON UNIVERSAL HOTEL
UNIVERSAL CITY, CA

      
      

|

      
      

FRIDAY TO SUNDAY
MAY 5 TO 7, 2023



Why You Should Support the Conference


This conference is the premier event dedicated to bringing practicing clinicians across all 50 states together with leading experts in cancer genomics to learn about the latest in precision cancer risk assessment and targeted therapeutics. As a sponsor of the 2023 conference, you will have a unique opportunity to build awareness and network with a wide cross-section of clinicians providing oncology care in diverse practice settings across the U.S., and internationally-recognized leaders at the forefront of integrating cancer genomics discovery into clinical care.

Exhibit space is available to companies interested in participating in this conference through exhibition, on a first-come first-served basis.

 

Exhibitor and Sponsorship Prospectus:
Click Here

 

Exhibitor/Sponsor Application:
Click Here


For more information, please contact [email protected] to discuss customized sponsorship packages!
 

The Division of Clinical Cancer Genomics thanks its committees for their volunteer efforts and for making this event possible.


We gratefully acknowledge the growing list of sponsors and exhibitors for the 11th Annual Clinical Cancer Genomics and Genetics Conference - From Precision Medicine to Precision Prevention: Joining Forces Across the Spectrum of Care.

These industry leaders make it possible to bring the latest in evidence-based advances in cancer genomics and precision medicine to clinicians in diverse practices across the U.S. and around the world.

 

SPONSORS

  PLATINUM  

AstraZeneca Pharmaceuticals


  SILVER  

Exact Sciences


Other Sponsors

 
CancerIQ
 

Invitae
 

 


Recursion

 


EXHIBITORS



Ambry Genetics

 


Astellas Oncology
 

BAYER
 


FamGenix
 

Foundation Medicine
 


GRAIL
 


Immunovia, Inc.

 


Lilly Oncology
 

Menarini Stemline


MERCK
 


Myriad

 


National Consortium
of Breast Centers

 


Novartis Oncology
 


PFIZER
 


Sanofi

 
 

TEMPUS LABS, INC.